Search results
Results from the WOW.Com Content Network
Lupin's South African subsidiary, Pharma Dynamics (PD) [35] is the fastest growing and the 4th largest generic company in the South African market (IMS). [citation needed] The company is a market leader in the Cardiovascular segment and has a growing presence in Neurology, Gastroenterology and the Over the Counter (OTC) segments.
Nearly a week after Lupin Pharmaceuticals announced a voluntary recall of two types of blood pressure medications, the company continues to see its stock price slide (though the hit could have ...
Another pharmaceutical company is recalling a blood pressure medication that could increase the risk of cancer if taken in large amounts. On Wednesday, Lupin Pharmaceuticals recalled four lots of ...
Gupta joined Lupin in 1993, [3] and became CEO in 2013. Gupta was the chairman and CEO of Lupin Pharmaceuticals Inc, from 2003 to 2013, and grew the US business from 5% to over 45% of Lupin's total turnover. [2] The US is Lupin's largest market. [citation needed] Lupin's estimated annual cost savings to the US health system is approximately $15 ...
This listing is limited to those independent companies and subsidiaries notable enough to have their own articles in Wikipedia. Both going concerns and defunct firms are included, as well as firms that were part of the pharmaceutical industry at some time in their existence, provided they were engaged in the production of human (as opposed to veterinary) therapeutics.
Gupta was married to Manju and lived in Mumbai. He is survived by his wife and five children: four daughters and one son. [1] Their daughter Vinita D. Gupta is based in United States and is the Group President & CEO and son Nilesh Gupta is the Managing Director based in India.
He is the only son of Desh Bandhu Gupta, who founded Lupin in 1968. [3] His eldest sister, Vinita D. Gupta, is the CEO. [citation needed]He has a bachelor's degree in chemical engineering from the University Department of Chemical Technology, Mumbai, and an MBA from the Wharton School, University of Pennsylvania, U.S. in 2002, [3] [1] where he specialized in healthcare, strategic management ...
In 1975, he joined Lupin Limited and worked there as first line manager for almost 8 years. In 1983, he resigned from Lupin and started his own company Bestochem in Partnership. In 1994, he withdrew his ownership from Bestochem and in 1995 incepted Mankind Pharma along with his younger brother Rajeev Juneja with an investment of ₹ 50 lakhs ...